Doctor profile · Federal record

Dr. Tyron Alli, M.D.

Gastroenterology Physician (CMS: Gastroenterology) · Gastroenterology Physician · Omaha, NE

  • NPI 1447225784
  • Accepts Medicare
  • 37 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
8901 Indian Hills Dr, Suite 200
Omaha, NE 681144057
(402) 397-7057
fax (402) 397-6656

Credentials & registration

NPPES · NUCC
NPI registered
February 2006 — 20 yrs on file
Profile last updated
December 8, 2009
Year of graduation
1989 — 37 yrs since
Specialty taxonomy
207RG0100X — NUCC code
State licenses (2)
Nebraska #19937 · Iowa #30899
Medicaid
NE #47077295213

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1447225784. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
27,994
Distinct HCPCS
10
Medicare allowed
$773,860
HCPCS Description Services Patients Avg allowed
J3380 Injection, vedolizumab, 1 mg 22,500 57 $22
J1745 Injection, infliximab, excludes biosimilar, 10 mg 4,110 42 $33
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare 200 200 $227
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 195 100 $73
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope 163 161 $91
99214 Established patient office or other outpatient visit, 30-39 minutes 109 97 $118
36415 Insertion of needle into vein for collection of blood sample 85 71 $8
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 81 61 $58
96413 Administration of chemotherapy into vein, 1 hour or less 62 47 $111
45380 Biopsy of large bowel using a flexible endoscope 58 58 $123

In context: peer comparison

Among 25 peers in Omaha Gastroenterology Physician, average services per provider: 429. This provider delivers 65× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,637
Transactions
56
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Regeneron Healthcare Solutions, INC. 10 $398.80
Abbvie INC. 11 $392.31
Phathom Pharmaceuticals, INC. 5 $391.22
Gilead Sciences, INC. 8 $382.88
Janssen Biotech, INC. 4 $261.79
Ardelyx, INC. 3 $168.37
Lilly USA, LLC 2 $144.56
Intercept Pharmaceuticals, INC. 1 $124.90
Genzyme Corporation 1 $97.37
Pfizer INC. 1 $70.76
Madrigal Pharmaceuticals 3 $57.39
Salix Pharmaceuticals, A Division of Bausch Health US, LLC 2 $46.27
Ironwood Pharmaceuticals, INC 3 $45.33
Boehringer Ingelheim Pharmaceuticals, INC. 1 $20.26
Qol Medical, LLC 1 $19.64

By nature of payment

Food and Beverage
$2,637

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,034
Patients
427
Total drug cost
$231,862
Drug Type Claims Patients Total cost
Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg) Brand 281 275 $6,895
Pantoprazole Sodium Generic 171 49 $2,377
Dicyclomine Hcl Generic 153 37 $4,253
Omeprazole Generic 94 30 $1,319
Mercaptopurine Generic 50 0 $4,098
Ursodiol Generic 44 0 $8,152
Linzess (Linaclotide) Brand 40 0 $23,047
Amitriptyline Hcl Generic 35 11 $397
Colestipol Hcl Generic 33 13 $1,903
Metoclopramide Hcl Generic 28 0 $261

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Tyron Alli's medical specialty?
Dr. Tyron Alli practices Gastroenterology Physician in Omaha, NE.
Where does Dr. Tyron Alli practice?
Dr. Tyron Alli practices at 8901 Indian Hills Dr, Omaha, NE 681144057. Office phone: 4023977057.
What is Dr. Tyron Alli's NPI?
Dr. Tyron Alli's National Provider Identifier (NPI) is 1447225784, issued by NPPES.
Does Dr. Tyron Alli accept Medicare assignment?
Yes. Dr. Tyron Alli accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tyron Alli commonly perform?
Top Medicare-reported procedures in 2023: Injection, vedolizumab, 1 mg (HCPCS J3380); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Removal of polyps or growths of large bowel using an endoscope with mechanical snare (HCPCS 45385). Source: CMS Medicare Physician & Other Practitioners file.